Concepedia

Maciej Kołodziej

MK

Statistics

Publications

6

Citations

221

H-Index

6

Active since

2011

Affiliations

Medical University of Silesia(Current)

Poznan University of Medical Sciences

National Centre for Nuclear Research

Jagiellonian University

Medical University of Warsaw

Maciej Kołodziej is an author at Medical University of Silesia specializing in medicine, neuroendocrine tumor therapy, and oncology.

ORCID

Publications per year

2011–2023

6

Publications

6

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)

Anna Sowa‐Staszczak, Dorota Pach, Robert Chrzan et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 109 citations · Full text

, , +11

Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

Jolanta Kunikowska, Anna Zemczak, Maciej Kołodziej et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 54 citations · Full text

, , +17

The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET

Anna Zemczak, Paweł Gut, Dariusz Pawlak et al. · International Journal of Endocrinology · 2021 · 21 citations · Full text

, , +17

Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms

Marek Saracyn, Adam Daniel Durma, Barbara Bober et al. · Nutrients · 2022 · 13 citations · Full text

, , +17

Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center

Adam Daniel Durma, Marek Saracyn, Maciej Kołodziej et al. · Cancers · 2023 · 13 citations · Full text

, , +17

1–5 of 6